berotek has been researched along with Multiple Sclerosis in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response relationship was similar within the non-asthma patients." | 1.40 | Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. ( Lee, CT; Lin, FC; Tsai, CP, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yong, HY | 1 |
| McKay, KA | 1 |
| Daley, CGJ | 1 |
| Tremlett, H | 1 |
| Tsai, CP | 1 |
| Lin, FC | 1 |
| Lee, CT | 1 |
1 review available for berotek and Multiple Sclerosis
| Article | Year |
|---|---|
Drug exposure and the risk of multiple sclerosis: A systematic review.
Topics: Adrenergic beta-2 Receptor Agonists; Antirheumatic Agents; Fenoterol; Histamine H1 Antagonists; Huma | 2018 |
1 other study available for berotek and Multiple Sclerosis
| Article | Year |
|---|---|
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Case-Control Studies; Child; Chil | 2014 |